SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment

SARS-CoV-2 nasopharyngeal shedding contributes to the spread of the COVID-19 epidemic. Among 3271 COVID-19 patients treated at the Hospital University Institute Méditerranée Infection, Marseille, France from 3 March to 27 April 2020, tested at least twice by qRT-PCR, the median SARS-CoV-2 nasopharyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Drancourt, Michel, Cortaredona, Sébastien, Melenotte, Cléa, Amrane, Sophie, Eldin, Carole, La Scola, Bernard, Parola, Philippe, Million, Matthieu, Lagier, Jean-Christophe, Raoult, Didier, Colson, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150993/
https://www.ncbi.nlm.nih.gov/pubmed/34065871
http://dx.doi.org/10.3390/v13050890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150993/
https://www.ncbi.nlm.nih.gov/pubmed/34065871
http://dx.doi.org/10.3390/v13050890

Ejemplares similares